Cardiovascular Industry Partnering Deals Discussed in New CurrentPartnering Study
01 Oct 2012 • by Natalie Aster
The unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies is offered by the “Cardiovascular Partnering Terms and Agreements” report elaborated by CurrentPartnering.
The report provides a detailed understanding and analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cardiovascular technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Cardiovascular Partnering Terms and Agreements
Published: September, 2012
Price: US$ 2.695,00
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This report contains over 2,000 links to online copies of actual cardiovascular deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
More information can be found in the report “Cardiovascular Partnering Terms and Agreements” by CurrentPartnering.
To order the report or ask for sample pages contact [email protected]